A Randomized, Open-label, Oral Dose, Crossover Study to Compare the Safety and Pharmacokinetics Between Co-administration and Fixed Dose Combination of DWC20155 and DWC20156 in Healthy Subjects
Latest Information Update: 16 Jan 2020
At a glance
- Drugs DWC 20155 (Primary) ; DWC 20156 (Primary) ; DWJ 1366
- Indications Gastrointestinal ulcer
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
- 14 Feb 2017 Status changed from not yet recruiting to completed.
- 08 Nov 2016 New trial record